# A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer

> **NCT06758544** · PHASE1,PHASE2 · RECRUITING · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 18 (estimated)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Oncolytic virus VRT106
- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT06758544
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-17
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-11-30
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06758544

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06758544, "A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06758544. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*